Aeternum Health annual ebitda
2011
2012
2013
2014
2015
2016
2023
2023
2024
2024
2025
Aeternum Health EBITDA Growth & History (AETN)
Aeternum Health's calculated EBITDA was −$269,274 for fiscal 2025.
View full Aeternum Health company overviewAeternum Health annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$269,274 | $111,215 | — |
| 2024 · Dec 31 | 2024-12-31 | −$380,489 | $171,872 | — |
| 2024 · Feb 29 | 2024-02-29 | −$584,175 | −$330,784 | — |
| 2023 · Dec 31 | 2023-12-31 | −$552,361 | — | — |
| 2023 · Feb 28 | 2023-02-28 | −$253,391 | — | — |
| 2016 | 2016-02-29 | −$81,434 | $612 | — |
| 2015 | 2015-02-28 | −$82,046 | −$6,537 | — |
| 2014 | 2014-02-28 | −$75,509 | $74,924 | — |
| 2013 | 2013-02-28 | −$150,433 | $23,359 | — |
| 2012 | 2012-02-29 | −$173,792 | $16,083 | — |
| 2011 | 2011-02-28 | −$189,875 | — | — |
Aeternum Health quarterly ebitda
Q2.11
Q3.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q4.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q2.17
Q2.18
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$270,879 | −$270,879 | — |
| Q1 2026 | 2026-03-31 | −$119,549 | −$142,281 | — |
| Q4 2025 | 2025-12-31 | −$82,353 | — | — |
| Q3 2025 | 2025-09-30 | −$120,943 | — | — |
| Q2 2025 · Jun 30 | 2025-06-30 | $0 | — | — |
| Q1 2025 · Mar 31 | 2025-03-31 | $22,732 | — | — |
| Q2 2018 | 2017-08-31 | −$9,546 | $5,725 | — |
| Q2 2017 | 2016-08-31 | −$15,271 | $19,348 | — |
| Q4 2016 | 2016-02-29 | −$23,730 | −$3,751 | — |
| Q3 2016 | 2015-11-30 | −$16,296 | $6,790 | — |
| Q2 2016 | 2015-08-31 | −$34,619 | −$2,452 | — |
| Q1 2016 | 2015-05-31 | −$6,789 | $25 | — |
| Q4 2015 | 2015-02-28 | −$19,979 | −$11,620 | — |
| Q3 2015 | 2014-11-30 | −$23,086 | −$8,246 | — |
| Q2 2015 | 2014-08-31 | −$32,167 | $1,428 | — |
| Q1 2015 | 2014-05-31 | −$6,814 | $11,901 | — |
| Q4 2014 | 2014-02-28 | −$8,359 | $26,368 | — |
| Q3 2014 | 2013-11-30 | −$14,840 | $12,837 | — |
| Q2 2014 | 2013-08-31 | −$33,595 | $18,402 | — |
| Q1 2014 | 2013-05-31 | −$18,715 | $17,317 | — |
| Q4 2013 | 2013-02-28 | −$34,727 | $5,937 | — |
| Q3 2013 | 2012-11-30 | −$27,677 | $11,858 | — |
| Q2 2013 | 2012-08-31 | −$51,997 | −$9,606 | — |
| Q1 2013 | 2012-05-31 | −$36,032 | $15,170 | — |
| Q4 2012 | 2012-02-29 | −$40,664 | — | — |
| Q3 2012 | 2011-11-30 | −$39,535 | $15,067 | — |
| Q2 2012 | 2011-08-31 | −$42,391 | −$6,374 | — |
| Q1 2012 | 2011-05-31 | −$51,202 | — | — |
| Q3 2011 | 2010-11-30 | −$54,602 | — | — |
| Q2 2011 | 2010-08-31 | −$36,017 | — | — |
Aeternum Health ebitda trends
Between the periods ended 2011-02-28 and 2025-12-31, Aeternum Health's ebitda decreased from −$189,875 to −$269,274, a change of −$79,399. The latest reported quarter, Q2 2026, shows −$270,879.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aeternum Health source filings ↗